Literature DB >> 21146219

B cells in spontaneous autoimmune diseases of the central nervous system.

Kerstin Berer1, Hartmut Wekerle, Gurumoorthy Krishnamoorthy.   

Abstract

B cells and their secreted products participate in the intricate network of pathogenic and regulatory immune responses. In human autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus and type 1 diabetes, a role for B cells and antibodies is well established. However, in multiple sclerosis (MS), despite the presence of autoantibodies, B cells were less considered as a major participant of autoimmune processes, until recently. Several lines of evidence now indicate a more active role for B cells in disease pathogenesis. In this review, we discuss the diverse roles of B cells in autoimmune diseases with particular focus on multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE) as well as the recently generated spontaneous EAE mouse models.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146219     DOI: 10.1016/j.molimm.2010.10.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  17 in total

1.  Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain.

Authors:  Meleshni Naicker; Strinivasen Naidoo
Journal:  Metab Brain Dis       Date:  2017-08-03       Impact factor: 3.584

Review 2.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

Review 4.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

5.  Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis.

Authors:  Tiffany C Blair; Minsha Manoharan; Stephanie D Rawlings-Rhea; Ian Tagge; Steven G Kohama; Julie Hollister-Smith; Betsy Ferguson; Randall L Woltjer; Meredith C Frederick; James Pollaro; William D Rooney; Larry S Sherman; Dennis N Bourdette; Scott W Wong
Journal:  J Neuroimmunol       Date:  2015-12-02       Impact factor: 3.478

6.  Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody.

Authors:  S J Bing; D Ha; G Ahn; J Cho; A Kim; S K Park; H S Yu; Y Jee
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 7.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

Review 8.  Brain-reactive antibodies and disease.

Authors:  B Diamond; G Honig; S Mader; L Brimberg; B T Volpe
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

9.  Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.

Authors:  Amy Perrin Ross; Aliza Ben-Zacharia; Colleen Harris; Jennifer Smrtka
Journal:  Front Neurol       Date:  2013-03-08       Impact factor: 4.003

Review 10.  Selected Aspects in the Pathogenesis of Autoimmune Diseases.

Authors:  György Nagy; Peter C Huszthy; Even Fossum; Yrjö Konttinen; Britt Nakken; Peter Szodoray
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.